Jens M.
- Country
- Germany
- Department
- Department of Internal Medicine I
Research Overview
- Phase 1/2 Study of Pumitamig Monotherapy or in Combination with Ipilimumab for First-Line Advanced or Unresectable Hepatocellular Carcinoma
- Phase 3 Study of Adjuvant Daraxonrasib Versus Observation in Patients With Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant or Adjuvant Chemotherapy
- Phase 3 Randomized Double-Blind Placebo-Controlled Trial of Efruxifermin in Non-Cirrhotic NASH/MASH with Fibrosis
Data & Insights
Has run more than one trial at 144 of 323 partner sites.
Specializations
Liver Cancer Treatment
Specializes in innovative approaches for treating hepatocellular carcinoma (HCC), exploring both intermediate and advanced stages of the disease. Investigates combination therapies involving immunotherapy and targeted treatments.
- Advanced HCC Management
- Immunotherapy Applications
- Post-surgical Recurrence Prevention
Focuses on developing treatment strategies for patients with varying liver function status and exploring alternatives to traditional interventions.
Biliary Tract Disorders
Conducts research in biliary tract cancer (BTC) and cholangiocarcinoma, including both intrahepatic and extrahepatic variants. Investigates novel therapeutic combinations incorporating targeted therapies and conventional treatments.
- Advanced Biliary Cancer Treatment
- Combination Therapy Approaches
- Post-surgical Treatment Strategies
Specializes in developing therapeutic approaches for various stages of biliary tract malignancies.
Metabolic Liver Disease
Focuses on treating non-alcoholic steatohepatitis (NASH) and metabolic dysfunction-associated steatohepatitis (MASH). Explores innovative therapeutic approaches for liver fibrosis and metabolic conditions.
- NASH/MASH Treatment
- Liver Fibrosis Management
- Novel Therapeutic Agents
Investigates treatments targeting both disease resolution and prevention of liver-related complications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.